Hubei Guangji Pharmaceutical Co., Ltd. (000952) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hubei Guangji Pharmaceutical Co., Ltd.

Why is Hubei Guangji Pharmaceutical Co., Ltd. ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of -2.85% and Operating profit at -227.95% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 26.67%, its profits have fallen by -17.5%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hubei Guangji Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Hubei Guangji Pharmaceutical Co., Ltd.

-100.0%

0.73

46.12%

China Shanghai Composite

15.45%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.85%

EBIT Growth (5y)

-227.95%

EBIT to Interest (avg)

0.62

Debt to EBITDA (avg)

6.37

Net Debt to Equity (avg)

0.74

Sales to Capital Employed (avg)

0.28

Tax Ratio

1.66%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2.71%

ROE (avg)

2.78%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.20

EV to EBIT

-14.06

EV to EBITDA

-66.88

EV to Capital Employed

1.66

EV to Sales

4.89

PEG Ratio

Dividend Yield

ROCE (Latest)

-11.78%

ROE (Latest)

-28.57%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 96.45 MM

RAW MATERIAL COST(Y)

Fallen by -78.25% (YoY

PRE-TAX PROFIT(Q)

Highest at CNY -25.13 MM

NET PROFIT(Q)

Highest at CNY -21.78 MM

EPS(Q)

Highest at CNY -0.06

-4What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 116.74 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.42 times

NET SALES(Q)

Fallen at -12.57%

Here's what is working for Hubei Guangji Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 96.45 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

Highest at CNY -25.13 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY -25.13 MM has Grown at 54.59%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY -21.78 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

At CNY -21.78 MM has Grown at 58.05%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY -0.06

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -78.25% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hubei Guangji Pharmaceutical Co., Ltd.

Debt-Equity Ratio

Highest at 116.74 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Net Sales

Fallen at -12.57%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Inventory Turnover Ratio

Lowest at 1.42 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio